EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/15/2023
Back to search
Official data from USPTO
A DIVISION OF GENESIS CLINICAL DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
09/15/2023
Trademark type
Combined
Nice classes
44
Filing date
01/02/2019
Registration date
08/16/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2022
Last transaction
09/15/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2019-01-00
First use in commerce
2019-01-00
Drawing code
3
Owner type
16
Owner location
Hamilton, NJ
Examiner
NEHMER, JASON
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized term "GENESIS" below the phrase "A DIVISION OF" and above the phrase "CLINICAL DIAGNOSTICS" with a stylized depiction of a molecule consisting of fourteen spheres representing atoms that are connected by straight bands representing bonds wherein the letter "I" in "GENESIS" is represented by a vertical band connecting two atoms.
Holders and representatives
Holders
Medical Diagnostic Laboratories, LLC
Representatives
Christina E. Brule Heslin Rothenberg Farley & Mesiti P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical diagnostic testinginfectious disease diagnosis through molecular based polymerase chain reaction testing for viralfungal and bacterial infectionsgenetic testing by DNA analysis to detect gene mutations associated with the inherited susceptibility to cancer and to identify gene variants to predict the efficacy of certain drugs in a patient to treat a patient's disease or condition
Publications
History of USPTO decisions and trademark events.
50 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/15/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/15/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/15/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/16/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/16/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/12/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/10/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/30/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/30/2022
IUAF
USE AMENDMENT FILED
06/10/2022
EISU
TEAS STATEMENT OF USE RECEIVED
06/10/2022
DOCK
ASSIGNED TO EXAMINER
01/28/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/28/2021
TMBN
TTAB RELEASE CASE TO TRADEMARKS
11/16/2021
OP.T
OPPOSITION TERMINATED NO. 999999
11/16/2021
OP.D
OPPOSITION DISMISSED NO. 999999
11/16/2021
EXPT
EXPARTE APPEAL TERMINATED
01/11/2021
OP.I
OPPOSITION INSTITUTED NO. 999999
11/23/2020
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
11/23/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2020
PUBO
PUBLISHED FOR OPPOSITION
11/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/21/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/15/2020
EXPI
EX PARTE APPEAL-INSTITUTED
09/15/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
09/15/2020
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
09/15/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/29/2020
GNFR
FINAL REFUSAL E-MAILED
04/29/2020
CNFR
FINAL REFUSAL WRITTEN
04/29/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/06/2020
ALIE
ASSIGNED TO LIE
04/06/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/09/2019
GNSL
LETTER OF SUSPENSION E-MAILED
09/09/2019
CNSL
SUSPENSION LETTER WRITTEN
09/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/26/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/26/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/26/2019
GNRT
NON-FINAL ACTION E-MAILED
03/26/2019
CNRT
NON-FINAL ACTION WRITTEN
03/26/2019
DOCK
ASSIGNED TO EXAMINER
03/20/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/23/2019
NWAP
NEW APPLICATION ENTERED
01/05/2019
Continuous trademark protection
Get notified about every new filing that threatens A DIVISION OF GENESIS CLINICAL DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.